Investment
Emovo develops the world's only neural hand exoskeleton for motor-impaired users, at home. Raising seed round (CHF 1.2M, 60% closed).
- See stage.
- Healthcare
- Electronics
- Biotech and Pharma
Emovo Care develops a neural EMG interface (non-medical) and a robotic hand exoskeleton (medical device) for people with motor impairments, at home.
Our 1st product is a medical device exoskeleton to support hand impairments after stroke. Based on novel soft-robotics tech protected by 2 patents, the system is comfortable and simple to use, to support therapy both in clinical settings and at home.
The company operates an ISO-13485 compliant QMS, and already deployed several systems for clinical and academic research worldwide.
Our next development include a world-unique neural device controllable via non-invasive muscular signals.
Our long term vision is to develop devices that can do “therapy while living”: assist patients in their daily life to increase motivation, meaningfulness, and dose of motor therapy -ultimately allowing to achieve better clinical recovery and improve quality of life.
Sectors
Investment
Emovo develops the world's only neural hand exoskeleton for motor-impaired users, at home. Raising seed round (CHF 1.2M, 60% closed).